L Gugliotta
Overview
Explore the profile of L Gugliotta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
396
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Porta C, Buggia I, Bonomi I, Gugliotta L, Vianelli N, Centurioni R, et al.
Hematology
. 2016 Jul;
1(3):239-46.
PMID: 27406618
The enhanced platelet aggregation and thrombosis occurring in TTP is probably due to an unbalance between agents insulting endothelial integrity and natural antithrombotic factors, such as NO. Using a sensitive...
2.
Tortorella G, Calzolari M, Tieghi A, Muia N, Piccin A, Gugliotta L
Int J Cardiol
. 2015 Oct;
203:225-7.
PMID: 26512843
No abstract available.
3.
Barosi G, Besses C, Birgegard G, Briere J, Cervantes F, Finazzi G, et al.
Leukemia
. 2007 Jan;
21(2):277-80.
PMID: 17251900
A widely accepted definition of resistance or intolerance to hydroxyurea (HU) in patients with essential thrombocythemia (ET) is lacking. An international working group (WG) was convened to develop a consensus...
4.
Scamardella F, Maconi M, Albertazzi L, Gamberi B, Gugliotta L, Brini M
Lab Hematol
. 2006 Nov;
12(4):187-92.
PMID: 17118768
B-cell chronic lymphocytic leukemia (B-CLL) is a lymphoproliferative disease caused by impaired apoptosis regulation that leads to an abnormal survival and an accumulation of B-lymphocytes. Anti-apoptotic Bcl-2 and proapoptotic Bax...
5.
Russo D, Piccaluga P, Michieli M, Michelutti T, Visani G, Gugliotta L, et al.
Ann Hematol
. 2002 Sep;
81(8):462-6.
PMID: 12224004
Toxicity limits the use of anthracyclines in elderly sick patients and in heavily pretreated patients. Since the liposomal preparation of daunorubicin (DNR) (DaunoXome, or DNX) is expected to be less...
6.
Catani L, Vianelli N, Amabile M, Pattacini L, Valdre L, Fagioli M, et al.
Leukemia
. 2002 Aug;
16(9):1773-81.
PMID: 12200693
Although the transcription factor nuclear factor-erythroid 2 (NF-E2) is known to be functionally linked to the megakaryocytic lineage, little is known about its role in malignant megakaryocytes. We used real-time...
7.
Visani G, Lemoli R, Isidori A, Piccaluga P, Martinelli G, Malagola M, et al.
Bone Marrow Transplant
. 2001 Jul;
27(8):829-35.
PMID: 11477440
Reinforced chemotherapy based on a double high-dose consolidation regimen could be a different way to enhance in vivo purging prior to autologous stem cell transplantation (auto-SCT) in acute myeloid leukemia...
8.
Vianelli N, Valdre L, Fiacchini M, De Vivo A, Gugliotta L, Catani L, et al.
Haematologica
. 2001 Jun;
86(5):504-9.
PMID: 11410414
Background And Objectives: Idiopathic thrombocytopenic purpura (ITP) induces thrombocytopenia by means of an autoimmune mechanism. Despite the available therapies a subset of patients develop chronic refractory severe thrombocytopenia (i.e. a...
9.
Visani G, Gugliotta L, Tosi P, Catani L, Vianelli N, Martinelli G, et al.
Eur J Haematol
. 2000 Sep;
64(3):139-44.
PMID: 10997878
Early hemorrhagic death (within the first 10 d of treatment [EHD]) is reported as the main cause of death during induction therapy for acute promyelocytic leukemia (APL). In order to...
10.
Sacchi S, Vinci G, Gugliotta L, Rupoli S, Gargantini L, Martinelli V, et al.
Haematologica
. 2000 May;
85(5):492-5.
PMID: 10800165
Background And Objective: Diagnostic criteria for essential thrombocythemia (ET) remain essentially negative, that is, exclusion of other myeloproliferative diseases and causes of reactive thrombocytosis. A platelet count above 600x10(9)/L is...